Challenges and Criteria for Single-Arm Trials Leading to an Added Benefit in German Health Technology Assessments.
Saved in:
| Title: | Challenges and Criteria for Single-Arm Trials Leading to an Added Benefit in German Health Technology Assessments. |
|---|---|
| Authors: | Tomeczkowski J; EGDE-Evidence-generating Data Evaluation, Dormagen, NW, Germany. joerg@tomeczkowski.de., Heidbrede T; UCB BioSciences GmbH, Monheim, NW, Germany., Eichinger B; Novartis Pharma GmbH, Nuremberg, BY, Germany., Osowski U; Merck Healthcare Germany GmbH, Weiterstadt, HE, Germany., Leverkus F; EGDE-Evidence-generating Data Evaluation, Berlin, BE, Germany., Schmitter S; Pfizer Pharma GmbH, Berlin, BE, Germany., Dintsios CM; Institute for Health Services Research and Health Economics, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, NW, Germany. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2025 Oct; Vol. 43 (10), pp. 1223-1233. Date of Electronic Publication: 2025 Jul 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-2027 |
|---|---|
| DOI: | 10.1007/s40273-025-01524-w |
